TOP PICK
Danaher Corp.

Market's not liking the negative growth compared to the pandemic. China has impacted it, not as many IPOs. The market just needs to look beyond all this. High quality, grows by acquisition. Great CEO. In all the right places. Good time to take a look for long-term returns. A company like this is a 5-10 year hold. Yield is 0.41%.

(Analysts’ price target is $282.58)
machinery
TOP PICK
Danaher Corp.

They work with branded drugs and are integral to FDA approval of drugs. DHR products help product such drugs. $200 billion in drug earnings (from big pharma) that's about to come off-patent, and the generic companies will need DHR to help produce the generic versions. So, DHR benefits from the brands and the generics.

(Analysts’ price target is $274.42)
machinery
BUY ON WEAKNESS
Danaher Corp.

Does not own shares, waiting for price to fall.
Strong business that will perform well in the future.
Excellent assets. 
Wait before buying.

machinery
Unspecified
Danaher Corp.

It is in life science tools diagnostics. Biological drugs are one component and it has 75% in recurring revenue from re-usables. Should benefit from long term growth in personalized medicine.

machinery
BUY ON WEAKNESS
Danaher Corp.

Life science & environmental company.
High growth healthcare business.
Concern is that share price is too expensive.
Would wait for shares to fall before buying.
Price appreciation will be limited.

machinery
WATCH
Danaher Corp.

A healthcare company, offering services and consumables to that industry. Their diagnostics helped spike profits and shares. Has since pulled back. On her watch list, but the PE has always been too hight. The PE has declined though. Interesting.

machinery
COMMENT
Danaher Corp.

It had a nice surge in earnings but its shares are pulling back slowly to its FMV which had been up to 5 1/2 BV.

machinery
HOLD
Danaher Corp.

One of those businesses you don't have to sell. Great compounders over the long term. In this environment, will probably be acquiring. Lots of M&A optionality. Extremely well run. If you own it, hold. Never gets extremely cheap, so you have to hold your nose and just buy.

machinery
BUY
Danaher Corp.
They will spin off their slower-growing water quality business, so that's a catalyst. China's big Covid outbreak will breathe life into their Covid-testing business. Good managers who solve problems.
machinery
BUY
Danaher Corp.
One of the world's largest companies. Like the Canadian Tire of the healthcare business. Sells solutions and technology for biotesting, etc. Always acquiring, and then spins off. Unbelievable long-term results, which should continue. Difficult to understand, so he stays away.
machinery
HOLD
Danaher Corp.
An industrial in the life sciences. High quality company generating consistently growing free cashflows. He's always liked the life sciences area because laboratories need to be given products, and experiments continue. Covid involvement has ended. Great ROIC and margins. A good buy when it gets under 20x earnings.
machinery
PAST TOP PICK
Danaher Corp.
(A Top Pick Nov 08/21, Down 13%) Are masters of buying businesses, extracting value from all kinds of them. Owned this since 2016, but shares are down this year, making it a buy on weakness.
machinery
COMMENT
Danaher Corp.
It is a larger weight holding in their health care fund. It is well diversified and does fine during market downturns. One of his favourite blue chips in the S&P 500.
machinery
BUY
Danaher Corp.
He recommends it, but has had a rough year. It did good business during Covid, mostly in Covid testing. But this created tough comparisons. Recently, it reported an excellent quarter. DHR reported a big top and bottom line beat and gave robust full-year and current-quarter guidance. Share have been rallying ever since. They are genuises in integrating businesses they buy. Also, 75% of their business is recurring revenues.
machinery
BUY ON WEAKNESS
Danaher Corp.
He;s been buying this as it's been going down. He really likes it now. DHR is in talks to make an acquisition in life sciences. Shares are pressured because of PCR testing as the street feels that Covid is going away. Has a low PE and offers good growth.
machinery
Showing 1 to 15 of 43 entries

Danaher Corp.(DHR-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 5

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 7

Stockchase rating for Danaher Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Danaher Corp.(DHR-N) Frequently Asked Questions

What is Danaher Corp. stock symbol?

Danaher Corp. is a American stock, trading under the symbol DHR-N on the New York Stock Exchange (DHR). It is usually referred to as NYSE:DHR or DHR-N

Is Danaher Corp. a buy or a sell?

In the last year, 7 stock analysts published opinions about DHR-N. 5 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Danaher Corp..

Is Danaher Corp. a good investment or a top pick?

Danaher Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Danaher Corp..

Why is Danaher Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Danaher Corp. worth watching?

7 stock analysts on Stockchase covered Danaher Corp. In the last year. It is a trending stock that is worth watching.

What is Danaher Corp. stock price?

On 2023-09-22, Danaher Corp. (DHR-N) stock closed at a price of $248.37.